Top News

• Mercks Sac-TMT Gets Win in Endometrial Cancer
• FDA Guide Reshaping Off-Label Communications: Legal Analysis
• DTC Crackdown Unfazed at Post-Makary FDA: Expert
• More FDA Turmoil: Drug, Biologics Leaders Removed
• Bayer sNDA for Hyrnuo Granted Priority Review
• Open Letter to Trump Urges FDA Push on Rare Diseases
• Regeneron Melanoma Trial Misses Primary Endpoint
• Health Affairs Commentary Says Makary Left FDA Weaker